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With Heart Failure With Preserved Ejection Fraction
Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study
Objectives We sought to determine whether structured exercise training (ET) improves maximal exercise capacity, left ven-
tricular diastolic function, and quality of life (QoL) in patients with heart failure with preserved ejection fraction
(HFpEF).
Background Nearly one-half of patients with heart failure experience HFpEF, but effective therapeutic strategies are sparse.
Methods A total of 64 patients (age 65  7 years, 56% female) with HFpEF were prospectively randomized (2:1) to super-
vised endurance/resistance training in addition to usual care (ET, n  44) or to usual care alone (UC) (n  20).
The primary endpoint was the change in peak VO2 after 3 months. Secondary endpoints included effects on car-
diac structure, diastolic function, and QoL.
Results Peak VO2 increased (16.1  4.9 ml/min/kg to 18.7  5.4 ml/min/kg; p  0.001) with ET and remained un-
changed (16.7  4.7 ml/min/kg to 16.0  6.0 ml/min/kg; p  NS) with UC. The mean benefit of ET was 3.3
ml/min/kg (95% confidence interval [CI]: 1.8 to 4.8, p  0.001). E/e= (mean difference of changes: 3.2, 95%
CI: 4.3 to 2.1, p  0.001) and left atrial volume index (milliliters per square meter) decreased with ET and
remained unchanged with UC (4.0, 95% CI: 5.9 to 2.2, p  0.001). The physical functioning score (36-Item
Short-Form Health Survey) improved with ET and remained unchanged with UC (15, 95% CI: 7 to 24, p  0.001).
The ET-induced decrease of E/e= was associated with 38% gain in peak VO2 and 50% of the improvement in
physical functioning score.
Conclusions Exercise training improves exercise capacity and physical dimensions of QoL in HFpEF. This benefit is associated
with atrial reverse remodeling and improved left ventricular diastolic function. (Exercise Training in Diastolic
Heart Failure–Pilot Study: A Prospective, Randomised, Controlled Study to Determine the Effects of Physical
Training on Exercise Capacity and Quality of Life [Ex-DHF-P]; ISRCTN42524037) (J Am Coll Cardiol 2011;58:
1780–91) © 2011 by the American College of Cardiology FoundationEpidemiological data indicate that the prevalence of
heart failure with preserved ejection fraction (HFpEF)
has significantly increased (1). Currently, over 50% of
atients with symptomatic heart failure experience
FpEF (1,2). Morbidity and mortality is high and
lmost comparable to heart failure with reduced ejection
raction (HFrEF) (1,2). However, in HFpEF, no phar-
acological therapy has shown to be effective in large
linical trials (3– 6).
See page 1792
In HFrEF, exercise training (ET) improves exercise
capacity and reduces morbidity (7). As suggested by
meta-analyses, the large HF-ACTION (Heart Failure: A
Controlled Trial Investigating Outcomes of Exercise
Training) trial also demonstrated a modest outcome
benefit with ET in HFrEF (8,9). Furthermore, condi-
tions known to be significantly associated with HFpEF
(e.g., endothelial dysfunction, systemic inflammation,
metabolic syndrome) are substantially improved by ET
(10 –12). Limited data suggest an attenuation of the
age-dependent decline in diastolic function with ET
(13). However, no multicenter, prospective, randomized
controlled trial (RCT) investigating also the effects of ET
on diastolic function has been performed in HFpEF.We conducted the multicenter, prospective RCT on
exercise training in diastolic heart failure to investigate
whether ET improves exercise performance, diastolic func-
tion, and quality of life (QoL) in patients with HFpEF.
Methods
We performed a prospective, multicenter, RCT in patients
with HFpEF. Structured endurance/resistance ET on top of
usual care (UC) was tested against UC alone.
Patient population. Symptomatic (New York Heart As-
sociation [NYHA] functional class II/III) outpatients older
than 45 years of age were included if they had preserved left
ventricular systolic function (left ventricular ejection fraction
50%), echocardiographically determined diastolic dys-
function (grade 1), sinus rhythm, and at least 1 of the
following cardiovascular risk factors: overweight, diabetes
mellitus, hypertension, hyperlipidemia, smoking. Exclusion
criteria were hemodynamically relevant valvular disorders,
pulmonary disease (vital capacity and/or forced expiratory
volume in 1 s 80% of age-dependent predicted value),
current angina pectoris, untreated coronary artery stenosis
50%, previous myocardial infarction, anemia (hemoglobin
12 g/dl), clinically relevant musculoskeletal disease, rest-
ing systolic blood pressure 150 mm Hg or diastolic blood
pressure 100 mm Hg, clinically relevant arrhythmia,
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tion within the previous 4 weeks.
Patients were recruited at 3 univer-
sity hospitals in Germany. The
German Health Authorities and
the ethics committees at each cen-
ter approved the study. Written
informed consent was obtained
from all patients before any study-
related procedure was performed.
Randomization, intervention.
Patients were randomized in a 2:1
ratio to ET or to UC. Blocked
randomization lists were gener-
ated. The allocation sequence was
implemented remotely via telefax
by the Coordination Center for
Clinical Trials Leipzig, Germany.
Patients randomized to ET par-
ticipated in a supervised, facility-
based training program consisting
of endurance and resistance train-
ing (32 sessions). During weeks 1
through 4, aerobic endurance
training (cycling 2/week) of in-
creasing intensity and duration
(from 20 to 40 min) was per-
formed. Training intensity was tai-
lored individually to a target heart
rate of 50% to 60% of peak oxygen
uptake (peak VO2) during baseline spiroergometry. From week
onward, weekly training frequencies were increased (3/
eek) and workload was increased to a target heart rate of 70%
f baseline peak VO2. Also starting at the fifth week, resistance
raining (bench press, leg press, leg curl, rowing machine,
riceps dip, latissimus pull down) was added twice per week.
esistance training was performed for 15 repetitions per
xercise per session at a workload corresponding to 60% to 65%
f the 1 repetition maximum measured at the end of week 4.
afety parameters such as blood pressure and heart rate as well
s training intensity and attendance at training sessions were
ocumented in a patient physical activity diary.
Patients randomized to the control group were instructed
o continue and maintain their usual daily activities. All
atients were on UC as recommended for HFpEF and
oncomitant diseases, which remained unchanged during
he trial.
linical assessment. At baseline and follow-up, patients
nderwent physical examination, echocardiography, cardio-
ulmonary exercise testing, 6-min walk test, and blood
ampling. QoL was assessed by the 36-Item Short Form
ealth Survey (SF-36) and the Minnesota Living With
eart Failure Questionnaire (MLWHFQ). Technical staff
ot involved in the training program and blinded to patient
Abbreviations
and Acronyms
CI  confidence interval
ET  exercise training
HFpEF  heart failure with
preserved ejection fraction
HFrEF  heart failure with
reduced ejection fraction
IQR  interquartile range
LAVI  left atrial volume
index
LVMI  left ventricular
mass index
MLWHFQ  Minnesota
Living With Heart Failure
Questionnaire
NT-proBNP  N-terminal
pro–B-type natriuretic
peptide
NYHA  New York Heart
Association
QoL  quality of life
RCT  randomized
controlled trial
SF-36  36-Item Short-
Form Health Survey
UC  usual care
VO2  oxygen consumptionssignment distributed the questionnaires to the patients. mPatients performed symptom-limited cardiopulmonary
xercise testing on a bicycle ergometer, beginning at a
orkload of 20 W and increasing stepwise at 20-W incre-
ents every 2 min. A 12-lead electrocardiogram was con-
inuously recorded; blood pressure was measured every 2
in. Cardiopulmonary variables were calculated using
rintouts of 10-s–averaged values.
ethods against bias regarding the primary endpoint.
one of the personnel involved in any exercise training
rocedure, or the physicians or investigators who were aware
f treatment group assignment were present during cardio-
ulmonary exercise testing. Peak VO2 was defined as the
ighest VO2 value of the last 30 s before termination of
xercise. A blinded investigator reviewed all measurements
nd confirmed correct peak VO2 determination. Ventilatory
anaerobic threshold was determined as described by Beaver
et al. (14) and using a blinded post-hoc analysis in a
nonpaired fashion (15).
Echocardiography. Echocardiography, including tissue
Doppler parameters and calculating left ventricular mass
index (LVMI) and left atrial volume index (LAVI), was
performed according to current guidelines of the American
Society of Echocardiography (16). A standard operating
procedure was used to ensure comparable results in all
centers. A reference center performed staff training prior to
the trial, and supervision and blinded core data evaluation
during the trial (F.E. at Göttingen). Diastolic dysfunction
was determined as described previously (17).
Biomarkers. Blood samples were taken in standardized
conditions after a 20-min supine resting period. All samples
were immediately centrifuged and stored at 80°C.
N-terminal pro–B-type natriuretic peptide (NT-proBNP)
was analyzed using a commercially available Elecsys
proBNP sandwich immunoassay (Elecsys 2010 analyzer,
Roche Diagnostics, Mannheim, Germany) and serum pro-
collagen type I-NP (PINP) using a commercial radioimmu-
noassay kit (Orion Diagnostica, Espoo, Finland).
Endpoints of the study. The primary endpoint was the
change in peak VO2 after 3 months follow-up. Secondary
endpoints included echocardiographic parameters of left
ventricular and atrial remodeling (LVMI, left ventricular
end-diastolic volume index, LAVI), systolic and diastolic
function (left ventricular ejection fraction, E/e=, e=, S/D,
E/A); parameters of exercise capacity (maximum workload,
VO2, and workload at the ventilatory anaerobic threshold,
aximum ventilatory exchange, increase of heart rate during
xercise); 6-min walk distance; QoL: SF-36 physical func-
ioning scale and physical, emotional, and total scores of the
LWHFQ; and serum biomarkers (NT-proBNP, PINP).
tatistical analysis. Changes within groups during
ollow-up were assessed by the t test for paired variables.
nalysis of covariance (ANCOVA) with the follow-up
easurement as dependent variable, baseline measurement
s covariate, and treatment group as fixed factor was applied
or all comparisons between the groups. Data were shown as
ean  SD. For skewed distributed laboratory data, pre-
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October 18, 2011:1780–91 Exercise Training in Heart Failure With Preserved Ejection Fractionsented at baseline and follow-up, data were shown by
median and interquartile range (IQR). For NT-proBNP
and PINP, t tests and ANCOVA were carried out on the
logarithmic scale, and the results were transformed back by
the exponential function, leading to estimates of ratios
(instead of differences) for within-group changes and the
between-group effect of intervention. Changes in NYHA
functional class were compared by Fisher exact test. For
explanatory purposes, post hoc analyses of the correlations
between the changes of the main outcome measures were
carried out. As well, possible correlations of training com-
pliance and leisure activities with the outcomes were exam-
ined in the intervention group in an exploratory manner.
Analyses were performed according to the intent-to-treat
principle. SPSS version 15.0 (SPSS Inc., Chicago, Illinois)
1
1
Screened for eligibility n=
(Age 45 years, dyspnea at exertion, pr
function & echo signs of DDys, presence of
factor, written informed consent)
Randomized
n=67
Training group
n=46
Contro
n
n=44 n
Available for analysis
n=64
≥
Figure 1 Flow Chart of the Trial
DDys  diastolic dysfunction.was the software used for statistical analyses. ASample size. A mean improvement of peak VO2 of 3
ml/min/kg (standard deviation of changes within groups 5
ml/min/kg) in the training group and no change in the
control group were expected. This pilot study was powered
primarily to demonstrate a significant improvement of peak
VO2 in the training group with type I and II error levels both
qual to 0.05. Secondarily, the study was powered to show
trend in favor of ET versus UC with type I and II error
evels both equal to 0.20. To meet both requirements, 2:1
andomization was the favorable solution, with 40 training
atients and 20 controls available for evaluation.
esults
tudy sample. Of 71 patients screened from January to
d systolic  
ast one risk 
Fulfilled any of the exclusion criteria
n=2
Clinically eligible, rejected participation
n=2
oup
Withdrawal of consent
n=2
Violation of baseline
spirometry protocol
n=11
71
eserve
 at le
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Exercise Training in Heart Failure With Preserved Ejection Fraction October 18, 2011:1780–91One patient (ET) was excluded due to violation of the
baseline spiroergometry protocol, and 1 patient in each
group withdrew consent. Baseline data are summarized in
Table 1.
Clinical and cardiac effects of exercise training. Cardio-
vascular medication was not different between the train-
ing and the control group (Table 1). During follow-up,
minor modifications were noted, with no significant
differences between the 2 groups. In any group, neither
body mass index nor blood pressure changed significantly
during follow-up (Table 2). ET significantly improved
symptoms, exercise capacity, diastolic function, and QoL
(Tables 2 and 3, Fig. 2). Mean increase of peak VO2 was
2.6 ml/min/kg in the training group compared with a
slight decrease of 0.7 ml/min/kg in the control group.
The net benefit of training was 3.3 ml/min/kg (95%
confidence interval [CI]: 1.8 to 4.8, p  0.001), trans-
lating into a number needed to treat of 3.5 (95% CI: 2.0
to 12.0, p  0.006) to achieve an increase of at least 3
Demographic Data, Physical Examination, and MTable 1 Demographic Data, Physical Exami
Variable
All Subje
(n  64
Female 36 (56%
Age, yrs 65 7
General examination
Body mass index, kg/m2 31 5
Waist/hip ratio 0.93 0
Heart rate, beats/min 66 1
Systolic blood pressure, mm Hg 140 1
Diastolic blood pressure, mm Hg 82 1
Characterization of heart failure
NYHA functional class of dyspnea
II 54 (84%
III 10 (16%
Orthopnea 12 (19%
Paroxysmal nocturnal dyspnea 8 (14%
Peripheral edema 24 (38%
Nocturia 39 (61%
Grade of diastolic dysfunction
I 46 (72%
II 18 (28%
Left ventricular ejection fraction, % 67 7
Medication
ACE inhibitor and/or AT1 receptor antagonist 42 (66%
Beta-blocker 32 (50%
Diuretics 29 (45%
Risk factors
Overweight (body mass index 25 kg/m2) 57 (89%
Diabetes mellitus 9 (14%
Hypertension 55 (86%
Hyperlipidemia 30 (47%
Ever smoked 36 (56%
Number of present risk factors 2.9 0
Values are n, frequency (%), or mean  SD.
ACE  angiotensin-converting enzyme; AT  angiotensin; NYHA l/min/kg at the individual level. At baseline, respiratory pxchange ratio was not different between the groups (ET:
.20  0.10 vs. UC: 1.18  0.11; p  0.05) and did not
hange after follow-up (difference of changes between
roups p  0.52). The improvement in peak VO2
corresponded to an increase in the 6-min walking dis-
tance in the training group by 24 m (p  0.001), although
he difference between ET and UC remained statistically
nsignificant.
The E/e= ratio improved significantly in the training
roup as compared with the control group. LAVI decreased
ignificantly in the training group whereas no relevant
hange occurred in controls. LVEF and volumes as well as
VMI did not change in any group.
NT-proBNP levels were similar at baseline (ET: 157  17
pg/ml; UC: 172 110 pg/ml) and did not change throughout
he study. There was a significant decrease of procollagen type
levels in ET patients as compared with UC (Table 2).
Compared with the control group, ET improved self-
eported physical functioning (SF-36 and the MLWHFQ
al History at Baselinen, and Medical History at Baseline
Treatment Group
Difference Between Groups
(p Value)
Training
(n  44)
Control
(n  20)
24 (55%) 12 (60%) 0.79
64 8 65 6 0.51
31 6 31 4 0.96
0.93 0.08 0.92 0.08 0.63
67 12 64 9 0.46
140 18 141 20 0.97
82 10 82 14 0.51
0.15
35 (80%) 19 (95%)
9 (20%) 1 (5%)
8 (18%) 4 (20%) 1.00
6 (14%) 2 (10%) 1.00
17 (39%) 7 (35%) 1.00
24 (55%) 15 (75%) 0.17
0.55
33 (75%) 13 (65%)
11 (25%) 7 (35%)
68 7 67 7 0.59
31 (70%) 11 (55%) 0.26
20 (45%) 12 (60%) 0.42
21 (48%) 8 (40%) 0.60
38 (86%) 19 (95%) 0.42
7 (16%) 2 (10%) 0.71
38 (86%) 17 (85%) 1.00
20 (46%) 10 (50%) 0.79
26 (59%) 10 (50%) 0.59
2.9 0.9 2.9 1.1 0.87
rk Heart Association.edicnatio
cts
)
)
.08
1
9
2
)
)
)
)
)
)
)
)
)
)
)
)
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October 18, 2011:1780–91 Exercise Training in Heart Failure With Preserved Ejection Fractionscales also improved significantly in the training group,
but differences between groups did not reach statistical
significance.
ET significantly improved NYHA functional class (p 
0.009 vs. controls). NYHA functional class improved in 14
patients in the training group (10 from NYHA functional
class II to I, 4 from NYHA functional class III to II) but
none of those in the control group.
Relationship between diastolic function, exercise performance,
and physical functioning. The increase in peak VO2 was
orrelated with the improvement in E/e= (r  0.37, p 
Spiroergometric Endpoint Data at Baseline andTable 2 Spiroergometric Endpoint Data at B
Variable Training
Peak VO2, ml/min/kg primary
Baseline 16.1 4.9
Follow-up 18.7 5.4
Change 2.6 (1.8 to 3
p value 0.001
Maximum workload, W
Baseline 117 38
Follow-up 129 41
Change 12 (7 to 17)
p value 0.001
Maximum exercise time, s
Baseline 648 22
Follow-up 700 25
Change 52 (27 to 77
p value 0.001
Anaerobic threshold VO2, ml/min/kg
Baseline 10.2 3.0
Follow-up 12.7 3.6
Change 2.5 (1.9 to 3
p value 0.001
Workload at anerobic threshold, W
Baseline 63 24
Follow-up 77 30
Change 14 (9 to 19)
p value 0.001
Maximum ventilatory exchange, l/min
Baseline 49.8 17
Follow-up 52.7 19
Change 2.9 (0.4 to
p value 0.09
 Mean BP during exercise, mm Hg
Baseline 29.0 17
Follow-up 30.1 15
Change 1.1 (2.8 to
p value 0.567
 Heart rate during exercise, beats/min
Baseline 56 20
Follow-up 58 20
Change 2 (2 to 6)
p value 0.31
Data are mean  SD or mean (95% confidence interval).
BP  blood pressure; VO2  oxygen uptake;   increase..002). According to the equation for the regression line tchange in peak VO2  1.00  0.42  change in E/e= 
rror), the observed difference of change in E/e= of 3.2 in
he ET group as compared with UC determines an im-
rovement of peak VO2 by 1.26 ml/min/kg. This corre-
sponds to 38% of the total improvement in peak VO2 (r 
0.37, p  0.002) (Fig. 3). The correlation of the change
in physical functioning with the improvement of E/e= was
even more pronounced (r  0.46, p  0.001) (Fig. 3).
he regression equation translates the difference in im-
rovement of E/e= into an improvement of the physical
unctioning score by nine points, corresponding to 50% of
3 Monthsne and After 3 Months
ent Group
Difference Between GroupsControl
16.7 4.7
16.0 6.0
0.7 (2.1 to 0.7) 3.3 (1.8 to 4.8)
0.34 0.001
114 35
111 41
3 (11 to 5) 15 (6 to 24)
0.45 0.001
630 211
615 245
15 (48 to 18) 66 (24 to107)
0.35 0.002
10.3 2.5
10.0 3.2
0.3 (1.3 to 0.6) 2.8 (1.7 to 4.0)
0.49 0.001
63 21
61 23
2 (8 to 4) 16 (8 to 25)
0.49 0.001
47.8 15.6
45.0 19.2
2.8 (7.9 to 2.2) 5.8 (0.1 to 11.6)
0.25 0.053
25.2 19.9
25.4 20.7
0.2 (6.0 to 6.3) 2.1 (4.2 to 8.3)
0.951 0.517
52 18
49 16
3 (8 to 2) 6 (1 to 13)
0.24 0.08Afteraseli
Treatm
.4)
4
1
)
.1)
.1
.5
6.2)
.2
.1
5.0)he entire effect of training on physical functioning.
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Exercise Training in Heart Failure With Preserved Ejection Fraction October 18, 2011:1780–91Safety, compliance. There were no serious adverse events
in any group. In the training group of 11 (25%) patients,
adverse events during or immediately after exercise occurred
without clinical relevance upon further investigation. Events
Echocardiographic, Clinical, and QoL Endpoint DTable 3 Echocardiographic, Clinical, and Qo
T
Variable Training
E/e= ratio
Baseline 12.8 3.2
Follow-up 10.5 2.5
Change 2.3 (3.0 to
p value 0.001
e= medial, cm/s
Baseline 5.4 1.2
Follow-up 6.3 1.3
Change 0.9 (0.6 to 1.1)
p value 0.001
S/D ratio
Baseline 1.38 0.3
Follow-up 1.40 0.3
Change 0.02 (0.08 to 0
p value 0.72
Left atrial volume index, ml/m2
Baseline 27.9 7.6
Follow-up 24.3 6.5
Change 3.7 (4.9 to
p value 0.001
Left ventricular ejection fraction, %
Baseline 67 7
Follow-up 66 6
Change 1 (5 to 2)
p value 0.33
Left ventricular volume index, ml/m2
Baseline 38.2 9.8
Follow-up 39.1 9.7
Change 0.9 (0.9 to 2.
p value 0.33
LVMI, g/m2
Baseline 116.8 27.4
Follow-up 117.5 38.4
Change 0.7 (10.7 to 1
p value 0.899
6-min walk distance, m
Baseline 545 86
Follow-up 569 88
Change 24 (10 to 38)
p value 0.001
Procollagen type I, g/l
Baseline* 38 (25 to 51)
Follow-up* 34 (25 to 42)
Follow-up/baseline ratio 0.96 (0.93 to 0.9
p value 0.01
SF-36 physical functioning scale
Number of responders 40
Baseline 65 22
Follow-up 79 19
Change 14 (8 to 19)
p value 0.001with suspected cardiovascular background were brief epi-sodes of palpitations (n  2) or dyspnea (n  3). Nine
patients (including 2 with dyspnea) reported mild muscu-
loskeletal discomfort during exercise, only 1 of them dis-
continued participation in exercise sessions during week 9.
t Baseline and After 3 Monthspoint Data at Baseline and After 3 Months
nt Group
Control Difference Between Groups
13.5 4.6
14.1 3.9
0.6 (0.5 to 1.8) 3.2 (4.3 to2.1)
0.26 0.001
6.0 1.5
5.5 1.3
0.5 (0.8 to0.1) 1.2 (0.8 to 1.7)
0.02 0.001
1.37 0.27
1.27 0.29
0.10 (0.22 to 0.03) 0.12 (0.03 to 0.26)
0.12 0.11
28.2 8.8
28.6 9.2
0.3 (0.7 to 1.4) 4.0 (5.9 to2.2)
0.53 0.001
66 7
67 8
1 (4 to 6) 1 (5 to 3)
0.75 0.54
38.7 9.5
39.7 10.6
1.0 (1.2 to 3.1) 0.1 (3.1 to 2.9)
0.36 0.93
108.8 28.9
113.2 26.4
4.4 (7.1 to 15.9) 0 (17.4 to 17.4)
0.435 1.000
551 86
568 80
17 (3 to 38) 6 (18 to 30)
0.10 0.63
34 (24 to 41)
35 (30 to 46)
1.02 (0.96 to 1.08) 0.95 (0.91 to 1.00)
0.55 0.049
20
71 20
67 24
4 (11 to 4) 15 (7 to 24)
0.30 0.001
Continued on next pageata aL End
reatme
1.6)
2
3
.11)
2.4)
8)
2.1)
9)In the training group, n  15 (34%) participated in 90%,
nesota
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the exercise sessions. Twenty-three training patients (52%)
and 10 controls (50%, p  0.05) reported high levels (more
than 2 h daily) of leisure-time physical activities.
Discussion
This is the first multicenter, prospective RCT that investi-
gated the effects of supervised, structured ET on exercise
capacity, diastolic function, and QoL in patients with
HFpEF. Endurance/resistance ET over 3 months was a
feasible, safe, and effective intervention: ET improved
functional capacity and QoL, and this was associated with
improved diastolic function.
Despite its high prevalence and prognostic relevance,
HFpEF is a disease without evidence-based therapies
(1– 6,18). ET has been found to improve exercise capacity
in HFrEF, mediated by cardiac and extracardiac mecha-
nisms (7,10 –12,19). Of particular interest, ET was able
to reduce diastolic stiffness in patients with HFrEF (19).
These observations, together with promising, albeit pre-
liminary, observations of beneficial effects of ET in
HFpEF, gave the rationale for the Ex-DHF pilot study
(20,21).
A few smaller, single-center studies have also investi-
gated ET in HFpEF. However, Gary et al. (20) and
Smart et al. (21) either did not provide a control group,
the effects of exercise training were investigated only
when linked to an educational program, or diastolic
function was not measured. Kitzman et al. (22) reported
the first single-center, single-blind RCT on ET in older
patients with HFpEF. Although diastolic function was
measured, the presence of diastolic dysfunction was not
required as a specific inclusion criterion, and diastolic
function was not determined using novel tissue Doppler
techniques. In Ex-DHF, diastolic function was investi-
ContinuedTable 3 Continued
T
Variable Training
MLWHFQ physical limitation scale
Number of responders 41
Baseline 14 10
Follow-up 9 8
Change 5 (7 to3
p value 0.001
MLWHFQ total scale
Number of responders 41
Baseline 25 20
Follow-up 17 17
Change 8 (12 to
p value 0.001
Data are n, mean  SD, or mean (95% CI), except where noted. *Dat
CI confidence interval; IQR interquartile range; MLWHFQ Min
Health Survey.gated as a main outcome measure during follow-up. And,in contrast to previous large trials, all patients were
diagnosed through positive demonstration of diastolic
dysfunction and strict exclusion of other potential causes
for impaired exercise capacity (3– 6,21–23). However,
although 55% of all included patients fulfilled the very
stringent diagnostic criteria defined by the European
Society of Cardiology that were published after finaliza-
tion of our study protocol, we are aware that we also
included patients better defined as having mild HFpEF
(18,24).
The training program was adopted from successfully
conducted studies in HFrEF, where ET improved rele-
vant clinical endpoints (7). Furthermore, the use of a
standardized patient diary enabled us to exclude changes
in leisure-time physical activity as a potential confounder
for the observed beneficial effects of ET. ET was a safe
and well-tolerated intervention; only a few minor and
conceivable training-related events were reported. Com-
pliance to intervention was high (81%), and only 3 of 67
patients did not complete the study. This rate is substan-
tially lower than in previous reports and has led to
increased power to detect beneficial effects regarding
diastolic function and exercise capacity (20,21). However,
it must be acknowledged that the low rate of adverse
events might to some extent be explained by the strict
exclusion of serious concomitant diseases. Compliance
would likely be lower in unselected patients than within
the settings of a voluntary clinical trial. Furthermore, our
study population suffered also from mild HFpEF; there-
fore our observations cannot be extrapolated easily to
patients with advanced HFpEF.
Impaired relaxation and diastolic left ventricular filling is
the pathophysiological hallmark of HFpEF. Echocardiog-
raphy including tissue Doppler assessment allows a detailed
characterization of diastolic function and estimation of
filling pressures (25–27). Morphological parameters, such as
nt Group
Control Difference Between Groups
19
13 10
11 9
2 (4 to 0) 3 (5 to 0)
0.08 0.04
19
23 19
21 19
2 (6 to 1) 5 (11 to 1)
0.19 0.07
edian (interquartile range).
Living With Heart Failure Questionnaire; SF-36 36-Item Short-Formreatme
)
4)
a are mleft atrial volume, are now additionally used for noninvasive
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parameters and LAVI serve as prognostic indicators (28,29).
Furthermore, the severity of diastolic dysfunction is related
to functional capacity in HFpEF (30,31). It therefore
appears to be reasonable that the improvement of diastolic
properties should be a treatment target in HFpEF. In
Figure 2 Changes of the Primary and Main Secondary Endpoint
Changes from baseline to follow-up of spiroergometric (A and B), echocardiograph
(p  0.001 for change within-group). VO2  oxygen consumption.Ex-DHF, ET significantly improved E/e= and left atrialvolume index, suggesting an improvement in left ventricular
filling pressures (27). Therefore, our data indicate that an
exercise intervention in patients with HFpEF has the
potential to improve diastolic function and induce reverse
atrial remodeling. Of note, because blood pressure and body
mass index did not change in either group, changes in blood
nd D), and QoL (E and F) outcome parameterss
ic (C apressure and body mass index are unlikely to be a major
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(32,33).
Patients with HFpEF experience reduced exercise
capacity, which is associated with a poor prognosis and
impaired QoL (20 –22,29,30,34,35). ET improved exer-
cise capacity in our training cohort, and this effect was at
least as large as reported in HFrEF (7,21). It is known
that aerobic capacity is partially determined by patient
motivation. However, with respect to respiratory ex-
change ratio values, it is unlikely that patient effort would
have biased our results. Since reduced exercise tolerance
is known to be a powerful prognostic indicator, the
increase in peak VO2 may reflect the potential of ET for
n improvement of clinical outcome in HFpEF (34).
owever, considering the results of HF-ACTION in
FrEF, the hypothesis that ET has prognostic impact
as yet to be proven (8,9). QoL was also reduced in our
atient cohort as described in previous studies (20 –22).
imilar to peak VO2, the extent of improvement in all
hysical dimensions is comparable to results in HFrEF,
trengthening the validity of our results (20,22).
The increase in peak VO2 with exercise was associated
ith improved diastolic function. There may be a major
oncern whether superior outcome in the training group
ight predominantly be attributable to the knowledge of
Figure 3 Association of Changes of Diastolic Function With Ch
Overall, change in E/e= was significantly correlated with changes in peak oxygen c
underwent ET significantly improved in peak VO2, 36-Item Short-Form Health Surve
rant), whereas patients in the control group remained unchanged during follow-upreatment allocation (single-blind), leading to bias in thexecution of the exercise test and in reporting, driven by
he expectations and wishes of both patients and exam-
ners. However, this argument does not apply to E/e=
ecause of blinded core evaluation. In addition, improve-
ents in E/e= and patient-reported physical functioning
ere significantly correlated (and patients were unaware
f their change in E/e=) (Fig. 3). Most importantly, this
orrelation was still significant after controlling within
he randomized groups (r  0.31, p  0.02), that is,
among patients who received the same treatment. These
findings cannot be explained by the group assignment
open to the patient; they rather strongly support the
hypothesis that reduction of E/e= is a relevant clinical
improvement associated with increased physical func-
tioning. Taken together, we were able to demonstrate
that improved diastolic function had a share in improve-
ment of functional capacity and subjective well-being.
Increased collagen turnover is associated with in-
creased ventricular stiffness and HFpEF (36). In our
study, ET was associated with a significant reduction in
procollagen type I plasma levels. Although such an
observed effect on 1 single parameter of the complex
collagen turnover may be misleading, it is reasonable to
speculate that the improvement in diastolic function may
s of Objective and Subjective Measures of Exercise Performance
ption (VO2) (left) and in SF-36 physical functioning scale (right). Patients who
ical functioning scale, and E/e= (green data point, shift to the upper left quad-
ata point).ange
onsum
y phys
(red dbe associated with reduced collagen turnover.
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in our patients. Even when most of the patients enrolled
meet the criteria for the diagnosis of HFpEF defined
by the European Society of Cardiology, levels of NT-
proBNP were still below the levels that were reported in
acutely decompensated HFpEF (37). Our finding of
NT-proBNP values at the upper limit of normal despite
symptomatic HFpEF with proven diastolic dysfunction is
also not unexpected, since the major stimulus for release
of BNP and its biologically inactive cleavage product
NT-proBNP is ventricular wall stress. However, wall
stress may be normal in patients with HFpEF and small,
but hypertrophied, ventricles (38). Furthermore, NT-
proBNP levels have been described to be heavily influ-
enced by comorbidities that were excluded in our study
population (39). The fact that NT-proBNP levels did not
reflect the improvement in physical function that has
been described also in HFrEF, supports the recom-
mended approach to use natriuretic peptides for a diag-
nosis of HFpEF only in conjunction with other param-
eters (18,39,40). Furthermore, it generates the hypothesis
that NT-proBNP may not be an ideal stand-alone
surrogate marker to evaluate the success of interventions
in HFpEF.
Study limitations. Although we provided blinded analyses
of the main outcome measures, the nature of ET inter-
ventions prohibits pure blinding. The lack of periodic
contact with rehabilitation staff in the control group
could have resulted in potential bias since the frequent
contact with rehabilitation staff may explain some of the
improvement seen in the intervention group. We inves-
tigated a relatively small number of younger and middle-
aged patients in short-term follow-up. Therefore, no
assumptions about the effects of ET in older, more
affected patients can be made. Although we cannot ascertain
the extent of the contribution of deconditioning and body
weight to symptom burden in our cohort, a relevant asso-
ciation between changes in body weight and outcome
parameters can be excluded. The potential contribution of
peripheral factors to changes in exercise capacity needs to
be investigated in future studies. Furthermore, the long-
term feasibility and tolerability of ET, the optimal type of
training, as well as the optimal training frequency and
intensity, need to be investigated in the future also in
broader populations with a wider range of stages of
HFpEF.
Conclusions
We have shown that a short-term supervised endurance/
resistance exercise program is feasible, safe, and effective in
patients with HFpEF. ET improves functional capacity,
diastolic function, and QoL in patients with HFpEF. ET
may therefore be considered as having potential as an
effective therapy in patients with HFpEF. Its long-termeffects and prognostic relevance should be evaluated in
future trials.
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